Yassine Belloum

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

M. Westphal, R. Simon, K. Pantel, 2020, Cells.

Current and Future Clinical Applications of ctDNA in Immuno-Oncology

K. Pantel, C. Gebhardt, Yassine Belloum, 2021, Cancer Research.

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond

K. Pantel, H. Wikman, Yassine Belloum, 2020, British Journal of Cancer.

Mutation analysis in individual circulating tumor cells depicts intratumor heterogeneity in melanoma.

S. Riethdorf, V. Thewes, A. Sartori, 2024, EMBO molecular medicine.

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients

M. Kwiatkowski, H. Schlüter, J. Izbicki, 2022, Cancers.